Sharon E. Murphy

9.9k total citations · 1 hit paper
205 papers, 7.1k citations indexed

About

Sharon E. Murphy is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Sharon E. Murphy has authored 205 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Molecular Biology, 99 papers in Physiology and 43 papers in Pharmacology. Recurrent topics in Sharon E. Murphy's work include Smoking Behavior and Cessation (96 papers), Pharmacogenetics and Drug Metabolism (43 papers) and Nicotinic Acetylcholine Receptors Study (41 papers). Sharon E. Murphy is often cited by papers focused on Smoking Behavior and Cessation (96 papers), Pharmacogenetics and Drug Metabolism (43 papers) and Nicotinic Acetylcholine Receptors Study (41 papers). Sharon E. Murphy collaborates with scholars based in United States, Russia and China. Sharon E. Murphy's co-authors include Stephen S. Hecht, Steven G. Carmella, Dorothy K. Hatsukami, Joni Jensen, Linda B. von Weymarn, Chap T. Le, Loı̈c Le Marchand, Anne M. Joseph, Jian‐Min Yuan and Daniel O. Stram and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Sharon E. Murphy

203 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival

2008 523 citations Andrew W. Bergen, Sharon E. Murphy et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon E. Murphy United States	45	3.3k	3.0k	1.2k	1.1k	943	205	7.1k
Steven G. Carmella United States	51	3.3k 1.0×	3.1k 1.0×	1.7k 1.4×	1.8k 1.6×	429 0.5×	190	7.8k
Ben van Ommen Netherlands	53	5.0k 1.5×	1.8k 0.6×	772 0.6×	479 0.4×	714 0.8×	192	9.2k
Emily Ho United States	56	4.9k 1.5×	1.0k 0.3×	799 0.7×	897 0.8×	356 0.4×	181	9.7k
Janne Hukkanen Finland	26	1.8k 0.6×	1.4k 0.4×	398 0.3×	585 0.5×	1.4k 1.5×	62	5.0k
James P. Kehrer United States	42	2.9k 0.9×	871 0.3×	688 0.6×	572 0.5×	457 0.5×	141	7.8k
Gérard Siest France	61	4.1k 1.2×	2.3k 0.8×	874 0.7×	364 0.3×	2.5k 2.6×	519	14.5k
John A. Milner United States	54	3.4k 1.0×	804 0.3×	626 0.5×	675 0.6×	492 0.5×	221	9.8k
Ping Yao China	47	2.3k 0.7×	1.1k 0.4×	565 0.5×	413 0.4×	400 0.4×	279	7.8k
W. Richmond United Kingdom	29	2.4k 0.7×	1.7k 0.6×	573 0.5×	232 0.2×	924 1.0×	73	11.6k
James D. Yager United States	43	3.5k 1.1×	518 0.2×	1.3k 1.1×	692 0.6×	507 0.5×	118	7.6k

Countries citing papers authored by Sharon E. Murphy

Since Specialization

Citations

This map shows the geographic impact of Sharon E. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon E. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon E. Murphy more than expected).

Fields of papers citing papers by Sharon E. Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon E. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon E. Murphy. The network helps show where Sharon E. Murphy may publish in the future.

Co-authorship network of co-authors of Sharon E. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon E. Murphy. A scholar is included among the top collaborators of Sharon E. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon E. Murphy. Sharon E. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murphy, Sharon E., Daniel O. Stram, Stephen S. Hecht, et al.. (2022). Association of Urinary Biomarkers of Smoking-Related Toxicants with Lung Cancer Incidence in Smokers: The Multiethnic Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 32(3). 306–314. 7 indexed citations

Christian, Paul, et al.. (2022). Surviving through story: Experiences of people with learning disabilities in the covid19 pandemic 2020–2021. British Journal of Learning Disabilities. 50(2). 270–286. 1 indexed citations

Bergen, Andrew W., Christopher S. McMahan, Carolyn M. Ervin, et al.. (2021). Multiethnic Prediction of Nicotine Biomarkers and Association With Nicotine Dependence. Nicotine & Tobacco Research. 23(12). 2162–2169. 4 indexed citations

Murphy, Sharon E., Bruce H. Alexander, Daniel O. Stram, et al.. (2021). Ethnic Differences of Urinary Cadmium in Cigarette Smokers from the Multiethnic Cohort Study. International Journal of Environmental Research and Public Health. 18(5). 2669–2669. 3 indexed citations

Smith, Tracy T., Joseph S. Koopmeiners, Katelyn Tessier, et al.. (2019). Randomized Trial of Low-Nicotine Cigarettes and Transdermal Nicotine. American Journal of Preventive Medicine. 57(4). 515–524. 22 indexed citations

McElroy, Joseph P., Steven G. Carmella, Mei Kuen Tang, et al.. (2019). Effects of cessation of cigarette smoking on eicosanoid biomarkers of inflammation and oxidative damage. PLoS ONE. 14(6). e0218386–e0218386. 19 indexed citations

Murphy, Sharon E.. (2017). Other People's Money. Johns Hopkins University Press eBooks. 9 indexed citations

Yuan, Jian‐Min, Heather H. Nelson, Steven G. Carmella, et al.. (2017). CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study. Carcinogenesis. 38(4). 411–418. 44 indexed citations

Yuan, Jian‐Min, Sharon E. Murphy, Irina Stepanov, et al.. (2016). 2-Phenethyl Isothiocyanate, Glutathione S-transferase M1 and T1 Polymorphisms, and Detoxification of Volatile Organic Carcinogens and Toxicants in Tobacco Smoke. Cancer Prevention Research. 9(7). 598–606. 27 indexed citations

10.

Yuan, Jian‐Min, Irina Stepanov, Sharon E. Murphy, et al.. (2016). Clinical Trial of 2-Phenethyl Isothiocyanate as an Inhibitor of Metabolic Activation of a Tobacco-Specific Lung Carcinogen in Cigarette Smokers. Cancer Prevention Research. 9(5). 396–405. 73 indexed citations

11.

Novalen, Maria, Peter Jatlow, Marilyn A. Huestis, et al.. (2015). Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation. Cancer Epidemiology Biomarkers & Prevention. 24(8). 1239–1246. 68 indexed citations

12.

Smith, Tracy T., Laura E. Rupprecht, Rachel L. Schassburger, et al.. (2015). Effects of MAO inhibition and a combination of minor alkaloids, β-carbolines, and acetaldehyde on nicotine self-administration in adult male rats. Drug and Alcohol Dependence. 155. 243–252. 40 indexed citations

13.

Patel, Yesha, Daniel O. Stram, Lynne R. Wilkens, et al.. (2014). The Contribution of Common Genetic Variation to Nicotine and Cotinine Glucuronidation in Multiple Ethnic/Racial Populations. Cancer Epidemiology Biomarkers & Prevention. 24(1). 119–127. 39 indexed citations

14.

Yuan, Jian‐Min, Lesley M. Butler, Y.-T. Gao, et al.. (2013). Urinary metabolites of a polycyclic aromatic hydrocarbon and volatile organic compounds in relation to lung cancer development in lifelong never smokers in the Shanghai Cohort Study. Carcinogenesis. 35(2). 339–345. 35 indexed citations

15.

Murphy, Sharon E., Linda B. von Weymarn, Melissa M. Schutten, Fekadu Kassie, & Jaime F. Modiano. (2011). Chronic Nicotine Consumption Does Not Influence 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone–Induced Lung Tumorigenesis. Cancer Prevention Research. 4(11). 1752–1760. 20 indexed citations

16.

Berg, Jeannette Zinggeler, et al.. (2007). Nicotine metabolism among African American and white smokers: Group and intraindividual differences in glucuronidation. Cancer Epidemiology and Prevention Biomarkers. 16. 1 indexed citations

17.

Hatsukami, Dorothy K., Anne M. Joseph, Mark LeSage, et al.. (2007). Developing the science base for reducing tobacco harm. Nicotine & Tobacco Research. 9. 537–553. 53 indexed citations

18.

Gopalakrishnan, Rajaram, Mark A. Morse, Jerry Lu, et al.. (1999). Expression of cytochrome P450 2A3 in rat esophagus: relevance to N-nitrosobenzylmethylamine. Carcinogenesis. 20(5). 885–891. 31 indexed citations

19.

Patten, Christopher, Lisa A. Peterson, & Sharon E. Murphy. (1998). Evidence for metabolic activation of N'-nitrosonornicotine and N-nitrosobenzylmethylamine by a rat nasal coumarin hydroxylase.. PubMed. 26(2). 177–80. 13 indexed citations

20.

Murphy, Sharon E., et al.. (1994). Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers.. PubMed. 3(5). 423–8. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact